Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

If you have $1,000 and a long investment horizon, this healthcare stock with a historically high yield is starting to turn its business around.

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...